Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema
Completed · Phase 2
Conditions studied: Chronic Hand Eczema
In brief
The purpose of this research trial was to test different strengths of a new trial medication, delgocitinib cream 1, 3, 8, and 20 mg/g, and to investigate how treatment with delgocitinib cream affects chronic hand eczema. This was judged by a range of assessments that rate the severity and extent of chronic hand eczema and its symptoms, as well as general health status and quality of life.
Key facts
- Study ID
- NCT03683719
- Run by
- LEO Pharma
- People needed
- 258
- Starts
- 2018-11-28
- Expected to finish
- 2020-04-20
- Last updated by the study team
- 2025-03-12
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Leo Pharma Investigational Site — Tucson, Arizona, United States
- Leo Pharma Investigational Site — Hialeah, Florida, United States
- Leo Pharma Investigational Site — Portland, Oregon, United States
- Leo Pharma Investigational Site — Portland, Oregon, United States
- Leo Pharma Investigational Site — Aarhus, Denmark
- Leo Pharma Investigational Site — Copenhagen, Denmark
- Leo Pharma Investigational Site — Hellerup, Denmark
- LEO Pharma Investigational Site — Herlev, Denmark
- Leo Pharma Investigational Site — Berlin, Germany
- Leo Pharma Investigational Site — Bochum, Germany
- Leo Pharma Investigational Site — Bremerhaven, Germany
- Leo Pharma Investigational Site — Dresden, Germany
- Leo Pharma Investigational Site — Düsseldorf, Germany
- Leo Pharma Investigational Site — Gera, Germany
- Leo Pharma Investigational Site — Göttingen, Germany
- Leo Pharma Investigational Site — Jena, Germany
- Leo Pharma Investigational Site — Kiel, Germany
- Leo Pharma Investigational Site — Kiel, Germany
- Leo Pharma Investigational Site — Langenau, Germany
- Leo Pharma Investigational Site — Lübeck, Germany
- Leo Pharma Investigational Site — Mahlow, Germany
- Leo Pharma Investigational Site — Mainz, Germany
- Leo Pharma Investigational Site — Memmingen, Germany
- Leo Pharma Investigational Site — München, Germany
- Leo Pharma Investigational Site — Selters, Germany
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.